GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy

THURSDAY, July 16, 2026-- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a higher risk for ischemic optic neuropathy (ION) compared with sodium-glucose cotransporter 2 inhibitors (SGLT2is) and dipeptidyl...